BOSTON, Jan. 3, 2018 /PRNewswire/ -- Jason Kelly, co-founder and CEO of Ginkgo Bioworks, the organism company, will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 9:30 AM Pacific Time at the Westin St. Francis Hotel in San Francisco, room Elizabethan C/D.
Following the recent partnership with Synlogic on the design and development of living medicines, as well as explosive growth after a $275 Million Series D financing round, Kelly's presentation will outline how synthetic biology is poised to transform everything from manufacturing to agriculture to the design and delivery of medicines.
About Ginkgo Bioworks
Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow products instead of manufacture them. The company's technology platform is bringing biotechnology into a wide range of new markets, enabling fragrance, beauty, food and health companies to make better products. For more information, visit www.ginkgobioworks.com.
Contacts
Media:
Bateman Group
Grace Emery
ginkgobioworks@bateman-group.com
Investors:
Argot Partners
Maeve Conneighton, 212-600-1902
maeve@argotpartners.com
SOURCE Ginkgo Bioworks